What is Vir Biotechnology, Inc.'s investments?

Vir Biotechnology, Inc. (VIR) reported investments of $332.97M in Q1 2026.

How has Vir Biotechnology, Inc.'s investments changed year-over-year?

Vir Biotechnology, Inc.'s investments increased by 52.6% year-over-year, from $218.14M to $332.97M.

Vir Biotechnology, Inc. VIR Investments

Investments at other companies

Krystal Biotech, Inc.KRYS

——

Sarepta Therapeutics, Inc.SRPT

——

AbbVieABBV

——

Other financials

Income statement

See full

Revenue-$29.0K-101%

Gross profit$1.2M-60.2%

Operating income-$132.3M+5.2%

Net income-$125.7M-3.9%

EPS (diluted)-$0.85+3.4%

Balance sheet

See full

Cash & equivalents$283.0M-23.1%

Total debt$95.6M-0.5%

Total equity$812.8M-22.1%

Total assets$1.0B-21.6%

Cash flow

See full

Operating cash flow-$132.4M-69.5%

CapEx$390.0K-76.1%

Free cash flow-$132.8M-66.5%

Valuation

See full

Market cap$1.68B+61.1%

Profitability

See full

Gross margin96.1%-2.7pp

Operating margin-720.8%-313pp

Net margin-676%-291pp

FCF margin-686.5%-273pp

Returns & leverage

See full

Return on equity-47.7%+3.6pp

Debt / equity0.1×0.0×

Current ratio7.1×+0.3×

Where this comes from

Reported directly by Vir Biotechnology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermInvestments.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s investments?: Vir Biotechnology, Inc. (VIR) reported investments of $332.97M in Q1 2026.
How has Vir Biotechnology, Inc.'s investments changed year-over-year?: Vir Biotechnology, Inc.'s investments increased by 52.6% year-over-year, from $218.14M to $332.97M.